The Best AI Stock to Own in the World Today is Trading for Just $25

“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.

Sarah Korman Biography and Net Worth

General Counsel of Absci

Sarah was General Counsel & Corporate Secretary at Neuvogen, and Head of Intellectual Property, Final Drug Products at Amgen.

Sarah Korman is currently General Counsel at AbSci

What is Sarah Korman's net worth?: The estimated net worth of Sarah Korman is at least $43,800.00 as of July 26th, 2021. Dr. Korman owns 10,000 shares of Absci stock worth more than $43,800 as of April 25th. This net worth evaluation does not reflect any other assets that Dr. Korman may own. Learn More about Sarah Korman's net worth.
How do I contact Sarah Korman?: The corporate mailing address for Dr. Korman and other Absci executives is , , . Absci can also be reached via phone at 360-949-1041 and via email at [email protected]. Learn More on Sarah Korman's contact information.
Has Sarah Korman been buying or selling shares of Absci?: Sarah Korman has not been actively trading shares of Absci within the last three months. Most recently, on Wednesday, February 9th, Sarah Korman bought 4,250 shares of Absci stock. The stock was acquired at an average cost of $7.96 per share, with a total value of $33,830.00. Learn More on Sarah Korman's trading history.
Who are Absci's active insiders?: Absci's insider roster includes Todd Bedrick (VP), Sarah Korman (General Counsel), Sean Mcclain (Insider), and Karen Mcginnis (Director). Learn More on Absci's active insiders.
Are insiders buying or selling shares of Absci?: In the last year, Absci insiders bought shares 1 times. They purchased a total of 222,222 shares worth more than $999,999.00. The most recent insider tranaction occured on March, 1st when Director Redmile Group, Llc bought 222,222 shares worth more than $999,999.00. Insiders at Absci own 11.6% of the company. Learn More about insider trades at Absci.
Information on this page was last updated on 3/1/2024.

Sarah Korman Insider Trading History at Absci

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
2/9/2022	Buy	4,250	$7.96	$33,830.00
7/26/2021	Buy	10,000	$16.00	$160,000.00	10,000

Sarah Korman Buying and Selling Activity at Absci

Absci Company Overview

Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to create biologics for patients. Its integrated drug creation platform is designed to improve upon traditional biologic drug discovery by using AI to simultaneously optimize multiple drug characteristics that may be important to development and therapeutic benefit. The company was founded in 2011 and is headquartered in Vancouver, Washington.

Today's Range

Now: $4.38

$4.27

$4.54

50 Day Range

MA: $5.20

$4.51

$6.59

2 Week Range

Now: $4.38

$1.11

$6.72

Volume

526,017 shs

Average Volume

1,512,250 shs

Market Capitalization

$494.02 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.36

The Best AI Stock to Own in the World Today is Trading for Just $25

From Banyan Hill Publishing | Ad

See how you can invest alongside him